AMSTAR能否也应用于非随机研究的系统评价?
Can AMSTAR also be applied to systematic reviews of non-randomized studies?
作者信息
Pieper Dawid, Mathes Tim, Eikermann Michaela
机构信息
Institute for Research in Operative Medicine, Witten/Herdecke University, Ostmerheimer Str, 200, Building 38, D-51109 Cologne, Germany.
出版信息
BMC Res Notes. 2014 Sep 6;7:609. doi: 10.1186/1756-0500-7-609.
BACKGROUND
There is a lack of an instrument to evaluate systematic reviews of non-randomized studies in epidemiological research. The Assessment of Multiple Systematic Reviews (AMSTAR) is widely used to evaluate the scientific quality of systematic reviews, but it has not been validated for SRs of non-randomized studies. The objective of this paper is to report our experience in applying AMSTAR to systematic reviews of non-randomized studies in terms of applicability, reliability and feasibility. Thus, we applied AMSTAR to a recently published review of 32 systematic reviews of non-randomized studies investigating the hospital volume-outcome relationship in surgery.
RESULTS
The inter-rater reliability was high (0.76), albeit items 8 (scientific quality used in formulating conclusions), 9 (appropriate method to combine studies), and 11 (conflicts of interest) scored moderate (≤0.58). However, there was a high heterogeneity between the two pairs of reviewers. In terms of feasibility, AMSTAR proved easy to apply to systematic reviews of non-randomized studies, each review taking 5-10 minutes to complete. We faced problems in applying three items, mainly related to scientific quality of the included studies.
CONCLUSIONS
AMSTAR showed good psychometric properties, comparable to prior findings in systematic reviews of randomized controlled trials. AMSTAR can be applied to systematic reviews of non-randomized studies, although there are some item specific issues users should be aware of. Revisions and extensions of AMSTAR might be helpful.
背景
在流行病学研究中,缺乏一种用于评估非随机研究系统评价的工具。多项系统评价评估(AMSTAR)被广泛用于评估系统评价的科学质量,但尚未针对非随机研究的系统评价进行验证。本文的目的是报告我们在将AMSTAR应用于非随机研究系统评价时在适用性、可靠性和可行性方面的经验。因此,我们将AMSTAR应用于最近发表的一篇综述,该综述对32项关于手术中医院规模与结局关系的非随机研究的系统评价进行了分析。
结果
评分者间信度较高(0.76),尽管第8项(制定结论时使用的科学质量)、第9项(合并研究的适当方法)和第11项(利益冲突)得分中等(≤0.58)。然而,两对评审员之间存在高度异质性。在可行性方面,AMSTAR被证明易于应用于非随机研究的系统评价,每项评价完成时间为5 - 10分钟。我们在应用三个项目时遇到了问题,主要与纳入研究的科学质量有关。
结论
AMSTAR显示出良好的心理测量特性,与随机对照试验系统评价的先前结果相当。AMSTAR可应用于非随机研究的系统评价,尽管有一些特定项目的问题用户应予以注意。对AMSTAR进行修订和扩展可能会有所帮助。
相似文献
BMC Res Notes. 2014-9-6
BMC Med Res Methodol. 2017-7-11
BMC Med Res Methodol. 2018-5-8
J Clin Epidemiol. 2014-12-30
引用本文的文献
BMC Public Health. 2024-7-11
Front Public Health. 2022
BMC Med Res Methodol. 2022-4-10
Plast Reconstr Surg Glob Open. 2021-11-22
本文引用的文献
J Clin Epidemiol. 2013-5-16
Ann Intern Med. 2013-2-19
PLoS One. 2012-11-15
J Clin Epidemiol. 2012-9-6
Int J Epidemiol. 2010-12-23